CANCER PREVENTION, CONTROL AND POPULATION RESEARCH (CPC) PROGRAM PROJECT SUMMARY/ABSTRACT The goal of the Cancer Prevention, Control and Population Research (CPC) Program is to develop and evaluate interventions that reduce the incidence and improve the outcomes of cancer in the Case Comprehensive Cancer Center (Case CCC) catchment area and beyond. Program members establish novel approaches in risk reduction, screening, and early detection. They also conduct research to implement and monitor improved delivery of recommended preventive services, therapies, and survivorship care after cancer diagnosis. The program is organized around 3 scientific aims: (1) Discover strategies and develop and implement behavioral interventions to reduce cancer risk and improve outcomes after cancer diagnosis; (2) Evaluate and facilitate effective cancer screening, surveillance and treatment policies and their impact on practice and the healthcare system; and (3) Discover and characterize genetic and environmental factors linked to cancer.
These aims reflect major working groups and initiatives that coalesces program members with other cancer center investigators through inter-programmatic collaborations that have impacted paradigms for patient care, health policy and the larger cancer research community. Extensive use of an array of shared resources, in particular Biostatistics, Cancer Outcomes, Genomics, and Tissue facilitate all aspects of member discoveries. Under the leadership of Gregory Cooper (Co-Leader) and Susan Flocke (Co-Leader) the CPC Program has 38 members including 30 full, 1 associate, and 7 clinical members. Members represent 20 departments, giving rise to a total of $10.8M in grant funding (annual direct costs), of which $8.2M is peer-reviewed and $2.3M is NCI-funded. Between 2012 and 2016, CPC program members published 1,174 publications. Cancer and program related publications included 25% inter-programmatic, 16% intra-programmatic, 6% inter- and intra- programmatic and 11% that involved collaborations with another Cancer Center. This highly effective Program has successfully created synergy among Case CCC CPC members and collaborations with investigators in other research Programs as evidenced by new initiatives in cancer prevention in underserved urban populations, tobacco control, new approaches to colon cancer screening and prevention, palliative care of patients with advanced cancer, and cancer risk in HIV infected individuals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-29
Application #
9696796
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
29
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Somasegar, Sahana; Li, Li; Thompson, Cheryl L (2018) No association of reproductive risk factors with breast cancer tumor grade. Eur J Cancer Prev 27:140-143
Gu, Xiaorong; Ebrahem, Quteba; Mahfouz, Reda Z et al. (2018) Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates. J Clin Invest 128:4260-4279
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Morrow, James J; Bayles, Ian; Funnell, Alister P W et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med 24:176-185
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266
Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:
Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151

Showing the most recent 10 out of 1227 publications